Ignite Creation Date:
2024-05-05 @ 10:50 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01196923
Status:
COMPLETED
Last Update Posted:
2016-07-27
First Post:
2010-09-07
Brief Title:
Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact CF-EAS-AC for the Treatment of Symptomatic Atrial Fibrillation
Sponsor:
CardioFocus
Organization:
CardioFocus
Study Overview
Official Title:
Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact CF-EAS-AC for the Treatment of Symptomatic Atrial Fibrillation
Status:
COMPLETED
Status Verified Date:
2016-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to confirm the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact in the treatment of atrial fibrillation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None